Samuel Mickelson, MD
Sleep Medicine · Atlanta, GANPI 1467410977
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,055 of the $1,353 with a category attached, or 78.0%. Livanova USA, Inc. accounts for 96.7% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,055 and has fallen 86.0% since, to $148 in 2025. That places this record below the midpoint for sleep medicine clinicians in GA, where the typical reported total is $2,223.
Across 5 payments — averaging $270.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$1K
- Intersect ENT, Inc.$31
- Resmed Corp$14
Across 198 payments — averaging $4753.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$941K
What the payments were for
- Speaking & faculty fees$1,05578%
- Food & beverage$29822%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 3 | $1,308 |
| Intersect ENT, Inc. | 1 | $31 |
| Resmed Corp | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THN Sleep Therapy$1,308
How this compares
$1,353 in reported general payments places this provider in the 40th percentile of 50 sleep medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CefuroximeCefuroxime Axetil | 14 | $356 |
| Montelukast Sodium | 21 | $96 |
| Zolpidem Tartrate | 11 | $79 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Atlanta
- Murad AssaadAtlanta$139K
- Nancy CollopAtlanta$28K
- Scott LeibowitzAtlanta$22K
- Chantale BransonAtlanta$17K
- Romy HoqueAtlanta$10K
- Jason YuAtlanta$3K
- Susan MuchaAtlanta$3K
- Abul MatinAtlanta$2K
- Paul ZoltyAtlanta$2K
- Crystal CassimereAtlanta$631
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.